Public Consultation

Patient group input requested for new Rapid Reviews on medicinal products for COVID-19.

EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. We believe patient groups can help us understand patients’ unique perspectives by collecting and presenting patients’ […]

Patient group input requested for a new Joint Assessment on a medicinal product for acute myeloid leukaemia (AML).

EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. We believe patient groups can help us understand patients’ unique perspectives by collecting and presenting patients’ […]

Patient group input requested for a new EUnetHTA Assessment on surgical techniques and devices for the treatment of benign prostatic hyperplasia.

EUnetHTA deems patient involvement very important in the production of Joint/Collaborative Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. We believe patient groups can help us understand patients’ unique perspectives by collecting and presenting patients’ […]

Open Call for Patient Input for a new Joint Assessment on a medicinal product for neuromyelitis optica spectrum (NMOSD) disorders.

Patient group input requested for a new Joint Assessment on a medicinal product for neuromyelitis optica spectrum disorders. EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or […]

REQueST Tool and its vision paper are now available for access.

The Registry Evaluation and Quality Standards Tool (REQueST) aims to support HTA organisations and other actors in guiding and evaluating registries for effective usage in HTA. Following public consultation, a finalised version of the tool, together with its vision paper, a document that explores the options for the long-term delivery, use and sustainability of REQueST […]

Open Call for Patient Input for a new Joint Assessment on a medicinal product for the prevention of vaso-occlusive crises in sickle cell disease (SCD) patients aged 16 years and over.

Patient group input requested for a new Joint Assessment on a medicinal product for the prevention of vaso-occlusive crises in sickle cell disease (SCD) patients aged 16 years and over. EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge […]

The public consultation of the revision of the methodological guideline “Process of information retrieval for systematic reviews and health technology assessments on clinical effectiveness” is OPEN (deadline 27th September, 2019)

We are pleased to announce that, as of today, a revised version of the methodological guideline “Process of information retrieval for systematic reviews and health technology assessments on clinical effectiveness”, produced within WP6 B2, has entered the public consultation phase. This consultation will be open until 27th September, 2019. PLEASE NOTE: This was initially 13th […]